suPARnostic® is prognostic across diseases

suPAR is a universal biomarker. The suPAR level is associated with the presence, severity, and progression of the disease, and in unselected patients, suPAR is one of the strongest prognostic biomarkers available to date.

The suPAR-level is, across diseases, directly linked to morbidity and mortality and can therefore be used to distinguish between non-survivors and survivors.

1000+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of four products:

suPARnostic POC+

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

POC+

Point-of-care finger prick

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates